Molecular Endocrinology, Vol 10, 1055-1065, Copyright © 1996 by Endocrine Society

ARTICLES

Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A

AJ Mason, PG Farnworth and J Sullivan
Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia.

Recombinant expression of human alpha- and beta A-inhibin subunit cDNAs in mammalian 293 cells results in the secretion of 20-53K free alpha- subunit-derived products, 30-105K alpha beta A-inhibin dimers, and 24- 110K beta A-activin dimers. The present study verifies that the wide variation in the size of these products is due to incomplete cleavage of the proteolytic processing sites and the differential glycosylation of the N-linked glycosylation site at amino acid number 302 in the alpha C-subunit. The identity of each of these products was established by mutagenesis of proteolytic processing sites and N-linked glycosylation sites, combined with the analysis of transfection products by immunoprecipitation and one- and two-dimensional SDS-PAGE (SDS/SDS-beta-ME). Transient expression of processing site mutants of the alpha- and beta A-subunits in 293 cells was used to generate microgram quantities of noncleavable 55K and 65K inhibin dimers, and noncleavable 110K activin A dimers. The 55K and 65K inhibin A forms were purified and found to be fully biologically active in a rat pituitary cell bioassay. The 110K high molecular weight (HMW) form of human activin A failed to show any FSH-releasing activity in the pituitary assay. Since radioactively labeled 55K and 65K inhibin A and 110K activin A remained intact after incubation with rat pituitary cells for 72 h, there appears to be no conversion of these dimers to lower molecular weight forms by proteolytic cleavage at additional sites. These results show for the first time that 55K and 65K inhibit A are intrinsically biologically active and do not require cleavage to the 32K form for activation. In contrast, cleavage of the 110K activin A precursor to the 24K form would appear to be necessary for activity.

This article has been cited by other articles:

				Y. Makanji, K. L. Walton, M. C. Wilce, K. L. Chan, D. M. Robertson, and C. A. Harrison Suppression of Inhibin A Biological Activity by Alterations in the Binding Site for Betaglycan J. Biol. Chem., June 13, 2008; 283(24): 16743 - 16751. [Abstract] [Full Text] [PDF]

				M. Antenos, M. Stemler, I. Boime, and T. K. Woodruff N-Linked Oligosaccharides Direct the Differential Assembly and Secretion of Inhibin {alpha}- and {beta}A-Subunit Dimers Mol. Endocrinol., July 1, 2007; 21(7): 1670 - 1684. [Abstract] [Full Text] [PDF]

				Y. Makanji, C. A. Harrison, P. G. Stanton, R. Krishna, and D. M. Robertson Inhibin A and B in Vitro Bioactivities Are Modified by Their Degree of Glycosylation and Their Affinities to Betaglycan Endocrinology, May 1, 2007; 148(5): 2309 - 2316. [Abstract] [Full Text] [PDF]

				F. Debieve, L. Hinck, J.-M. Biard, P. Bernard, and C. Hubinont Activin receptor expression and induction of apoptosis in rat blastocysts in vitro Hum. Reprod., March 1, 2006; 21(3): 618 - 623. [Abstract] [Full Text] [PDF]

				A. S. Dighe, F. J. Hayes, J. Khosravi, U. Bodani, and P. M. Sluss Comparison of Inhibin A Immunoassays: Recommendation for Adoption of Standardized Reporting Clin. Chem., April 1, 2004; 50(4): 767 - 769. [Full Text] [PDF]

				D.M. Robertson, T. Stephenson, and R.I. McLachlan Characterization of plasma inhibin forms in fertile and infertile men Hum. Reprod., May 1, 2003; 18(5): 1047 - 1054. [Abstract] [Full Text] [PDF]

				H. Kaneko, J. Noguchi, K. Kikuchi, and Y. Hasegawa Molecular Weight Forms of Inhibin A and Inhibin B in the Bovine Testis Change with Age Biol Reprod, May 1, 2003; 68(5): 1918 - 1925. [Abstract] [Full Text] [PDF]

				K.I. Parker, D.M. Robertson, N.P. Groome, and K.L. Macmillan Plasma Concentrations of Inhibin A and Follicle-Stimulating Hormone Differ Between Cows with Two or Three Waves of Ovarian Follicular Development in a Single Estrous Cycle Biol Reprod, March 1, 2003; 68(3): 822 - 828. [Abstract] [Full Text] [PDF]

				A. O. Bahathiq, R. L. Stewart, M. Wells, H. D. Moore, A. A. Pacey, and W. L. Ledger Production of Activins by the Human Endosalpinx J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5283 - 5289. [Abstract] [Full Text] [PDF]

				G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF]

				P. Thirunavukarasu, T. Stephenson, J. Forray, P. G. Stanton, N. Groome, E. Wallace, and D. M. Robertson Changes in Molecular Weight Forms of Inhibin A and Pro-{alpha}C in Maternal Serum during Human Pregnancy J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5794 - 5804. [Abstract] [Full Text] [PDF]

				W. E. Taylor, S. Bhasin, J. Artaza, F. Byhower, M. Azam, D. H. Willard Jr., F. C. Kull Jr., and N. Gonzalez-Cadavid Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E221 - E228. [Abstract] [Full Text] [PDF]

				S. L. Mellor, M. Cranfield, R. Ries, J. Pedersen, B. Cancilla, D. de Kretser, N. P. Groome, A. J. Mason, and G. P. Risbridger Localization of Activin {beta}A-, {beta}B-, and {beta}C-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers of {beta}C-Subunit J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4851 - 4858. [Abstract] [Full Text]

				D. B. Gardner, J. Sebastian, and W. L. Miller Estradiol Induces and Hyperglycosylates the Receptor for Ovine Gonadotropin-Releasing Hormone Endocrinology, January 1, 2000; 141(1): 91 - 99. [Abstract] [Full Text] [PDF]

				G. Wuytens, K. Verschueren, J. P. de Winter, N. Gajendran, L. Beek, K. Devos, F. Bosman, P. de Waele, M. Andries, A. J.M. v. d. E.-v. Raaij, et al. Identification of Two Amino Acids in Activin A That Are Important for Biological Activity and Binding to the Activin Type II Receptors J. Biol. Chem., April 2, 1999; 274(14): 9821 - 9827. [Abstract] [Full Text] [PDF]

				M. Hayashi, E. A. McGee, G. Min, C. Klein, U. M. Rose, M. v. Duin, and A. J. W. Hsueh Recombinant Growth Differentiation Factor-9 (GDF-9) Enhances Growth and Differentiation of Cultured Early Ovarian Follicles Endocrinology, March 1, 1999; 140(3): 1236 - 1244. [Abstract] [Full Text]

				M. Bläuer, S. Husgafvel, H. Syvälä, P. Tuohimaa, and T. Ylikomi Identification of a Nuclear Localization Signal in Activin/Inhibin ßA Subunit; Intranuclear ßA in Rat Spermatogenic Cells Biol Reprod, March 1, 1999; 60(3): 588 - 593. [Abstract] [Full Text]

				N. F. Gonzalez-Cadavid, W. E. Taylor, K. Yarasheski, I. Sinha-Hikim, K. Ma, S. Ezzat, R. Shen, R. Lalani, S. Asa, M. Mamita, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting PNAS, December 8, 1998; 95(25): 14938 - 14943. [Abstract] [Full Text] [PDF]

				A.-M. Andersson, J. Müller, and N. E. Skakkebæk Different Roles of Prepubertal and Postpubertal Germ Cells and Sertoli Cells in the Regulation of Serum Inhibin B Levels J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4451 - 4458. [Abstract] [Full Text]

				J. W. M. Martens, J. P. de Winter, M. A. Timmerman, A. McLuskey, R. H. N. van Schaik, A. P. N. Themmen, and F. H. de Jong Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells Endocrinology, July 1, 1997; 138(7): 2928 - 2936. [Abstract] [Full Text] [PDF]

				H. G. Burger and D. M. Robertson Editorial: Inhibin in the Male--Progress at Last Endocrinology, April 1, 1997; 138(4): 1361 - 1362. [Full Text] [PDF]